Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antihistamines and Alpha Blockers for Distal Ureter Stones
NCT06754410Phase 3Completed
- Sponsor
- South Valley University
- Start
- Mar 2021
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of cetirizine in ureteral calculus (4 arms), sponsored by South Valley University. Primary endpoint: Ureter Stone Free Rate at 4 weeks. Started Mar 2021; status: completed.
02
Drugs
cetirizine
03
Conditions
ureteral calculus
Beyond the preview
Go deeper on NCT06754410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06754410.